Reply: Intra-patient heterogeneity of BRAF mutation status: fact or fiction?

Br J Cancer. 2014 Oct 14;111(8):1679-80. doi: 10.1038/bjc.2014.247. Epub 2014 May 15.

Authors

L Heinzerling¹, G Schuler¹, A Hartmann², R Schneider-Stock³

Affiliations

¹ Department of Dermatology, University Hospital Erlangen, 91054 Erlangen, Germany.
² Department of Pathology, University of Erlangen-Nürnberg, 91054 Erlangen, Germany.
³ 1] Department of Pathology, University of Erlangen-Nürnberg, 91054 Erlangen, Germany [2] Experimental Tumor Pathology, Department of Pathology, University of Erlangen-Nürnberg, 91054 Erlangen, Germany.

No abstract available

Publication types

Letter
Comment

MeSH terms

Female
Genetic Heterogeneity*
Humans
Male
Melanoma / genetics*
Mutation, Missense*
Proto-Oncogene Proteins B-raf / genetics*
Skin Neoplasms / genetics*

Substances

Proto-Oncogene Proteins B-raf